Trial Profile
A Study to Evaluate the Relationship Between Choroidal Thickness and Response to Intravitreal Ranibizumab in Patients With Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration; Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 29 Apr 2016 New trial record